These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7689034)

  • 1. Chromosome changes in benign prostatic hyperplasia and their significance in the origin of prostatic carcinoma.
    Casalone R; Portentoso P; Granata P; Minelli E; Righi R; Meroni E; Pozzi E; Chiaravalli AM
    Cancer Genet Cytogenet; 1993 Jul; 68(2):126-30. PubMed ID: 7689034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gain and loss of chromosomes 1, 7, 8, 10, 18, and Y in 46 prostate cancers.
    König JJ; Teubel W; Romijn JC; Schröder FH; Hagemeijer A
    Hum Pathol; 1996 Jul; 27(7):720-7. PubMed ID: 8698318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetics of primary prostatic adenocarcinoma. Clonality and chromosome instability.
    Micale MA; Mohamed A; Sakr W; Powell IJ; Wolman SR
    Cancer Genet Cytogenet; 1992 Jul; 61(2):165-73. PubMed ID: 1638499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the extent and nature of cytogenetic events in prostatic adenocarcinoma: paraffin FISH vs. metaphase analysis.
    Micale MA; Sanford JS; Powell IJ; Sakr WA; Wolman SR
    Cancer Genet Cytogenet; 1993 Aug; 69(1):7-12. PubMed ID: 8374904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chromosomal abnormalities in carcinoma and hyperplasia of the prostate].
    Miyauchi T; Nagayama T; Maruyama K
    Nihon Hinyokika Gakkai Zasshi; 1992 Jan; 83(1):66-74. PubMed ID: 1373453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal evaluation of cytogenetic aberrations in prostatic cancer: tumours that recur in time display an intermediate genetic status between non-persistent and metastatic tumours.
    Alers JC; Krijtenburg PJ; Hop WC; Bolle WA; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    J Pathol; 1998 Jul; 185(3):273-83. PubMed ID: 9771481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome abnormalities in benign prostatic hyperplasia.
    Aly MS; Dal Cin P; Van de Voorde W; van Poppel H; Ameye F; Baert L; Van den Berghe H
    Genes Chromosomes Cancer; 1994 Apr; 9(4):227-33. PubMed ID: 7519044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal aberrations in benign prostatic hyperplasia patients.
    Altok M; Bağcı Ö; Umul M; Güneş M; Akyüz M; Uruç F; Uz E; Soyupek S
    Investig Clin Urol; 2016 Jan; 57(1):45-9. PubMed ID: 26966725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic analysis of four primary prostatic cultures.
    Brothman AR; Lesho LJ; Somers KD; Schellhammer PF; Ladaga LE; Merchant DJ
    Cancer Genet Cytogenet; 1989 Feb; 37(2):241-8. PubMed ID: 2467737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss and gain of chromosomes 1, 18, and Y in prostate cancer.
    König JJ; Teubel W; van Dongen JW; Romijn JC; Hagemeijer A; Schröder FH
    Prostate; 1994 Dec; 25(6):281-91. PubMed ID: 7527913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic analysis of 57 primary prostatic adenocarcinomas.
    Lundgren R; Mandahl N; Heim S; Limon J; Henrikson H; Mitelman F
    Genes Chromosomes Cancer; 1992 Jan; 4(1):16-24. PubMed ID: 1377005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
    Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
    J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome study of five cancers of the prostate.
    Atkin NB; Baker MC
    Hum Genet; 1985; 70(4):359-64. PubMed ID: 4018801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic analysis of six renal oncocytomas and a chromophobe cell renal carcinoma. Evidence that -Y, -1 may be a characteristic anomaly in renal oncocytomas.
    Crotty TB; Lawrence KM; Moertel CA; Bartelt DH; Batts KP; Dewald GW; Farrow GM; Jenkins RB
    Cancer Genet Cytogenet; 1992 Jul; 61(1):61-6. PubMed ID: 1638482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence in situ hybridization to assess transitional changes of aneuploidy for chromosomes 7, 8, 10, 12, 16, X and Y in metastatic prostate cancer following anti-androgen therapy.
    Kasahara K; Taguchi T; Yamasaki I; Karashima T; Kamada M; Yuri K; Shuin T
    Int J Oncol; 2001 Sep; 19(3):543-9. PubMed ID: 11494034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic study of four cancers of the prostate.
    Babu VR; Miles BJ; Cerny JC; Weiss L; Van Dyke DL
    Cancer Genet Cytogenet; 1990 Aug; 48(1):83-7. PubMed ID: 2372791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and pattern of karyotypic abnormalities in human prostate cancer.
    Brothman AR; Peehl DM; Patel AM; McNeal JE
    Cancer Res; 1990 Jun; 50(12):3795-803. PubMed ID: 2340524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic evaluation of 20 cultured primary prostatic tumors.
    Brothman AR; Peehl DM; Patel AM; MacDonald GR; McNeal JE; Ladaga LE; Schellhammer PF
    Cancer Genet Cytogenet; 1991 Aug; 55(1):79-84. PubMed ID: 1913611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic studies of prostatic cancer.
    Lundgren R
    Scand J Urol Nephrol Suppl; 1991; 136():1-35. PubMed ID: 1871551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.